Neurogenic Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer’s Disease

By Sreenivasmurthy Sravan Gopalkrishnashetty   Liu Jing-Yi   Song Ju-Xian   Yang Chuan-Bin   Malampati Sandeep   Wang Zi-Ying   Huang Ying-Yu   Li Min  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 272-272

MDPI

Access to resources Recommend Favorite

From Single Target to Multitarget/Network Therapeutics in Alzheimer’s Therapy

By Zheng Hailin   Fridkin Mati   Youdim Moussa  

Pharmaceuticals, Vol. 7, Iss. 2, 2014-01 ,pp. : 113-135

MDPI

Access to resources Recommend Favorite

Melatonin in Alzheimer’s Disease

By Lin Li   Huang Qiong-Xia   Yang Shu-Sheng   Chu Jiang   Wang Jian-Zhi   Tian Qing  

International Journal of Molecular Sciences, Vol. 14, Iss. 7, 2013-07 ,pp. : 14575-14593

MDPI

Access to resources Recommend Favorite

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy

By Boulebd Houssem   Ismaili Lhassane   Bartolini Manuela   Bouraiou Abdelmalek   Andrisano Vincenza   Martin Helene   Bonet Alexandre   Moraleda Ignacio   Iriepa Isabel   Chioua Mourad   Belfaitah Ali   Marco-Contelles José  

Molecules, Vol. 21, Iss. 4, 2016-03 ,pp. : 400-400

MDPI

Access to resources Recommend Favorite

Graveoline Analogs Exhibiting Selective Acetylcholinesterase Inhibitory Activity as Potential Lead Compounds for the Treatment of Alzheimer’s Disease

By Li Zeng   Mu Chaoyu   Wang Bin   Jin Juan  

Molecules, Vol. 21, Iss. 2, 2016-01 ,pp. : 132-132

MDPI

Access to resources Recommend Favorite